Imugene Limited - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Imugene Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Imugene Limited. The Group's principal activities are researching, developing and commercialising animal health technologies. Products include Poultry Productivity Enhancer, Avian Influenza (Bird Flu) Poultry, Coccidiosis, Classical Swine Fever and Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine. Its vaccines are developed from two platform technologies, namely, the fowl adenovirus (FAV) and porcine adenovirus (PAV). Its products improve the health and welfare of animals and reduce or eliminate the use of chemicals and drugs, particularly antibiotics, in production animals. Operations are carried out in Australia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report